Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old

• Status: Unknown status
• Trial end date: 2021-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study focus on the comparison of CAG regimen to the low dose cytarabine therapy in elderly AML patients who are unfit or unwilling to receive intensive chemotherapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jianxiang Wang
• Treatments: Aclacinomycins; Aclarubicin; Cytarabine

Criteria

Inclusion Criteria:

• Acute myeloid leukemia except APL

• ECOG PS：0-3

• Unfit or unwilling to receive intensive therapy

Exclusion Criteria:

• The one who has already received induction therapy no matter what the outcome is.

• Active cancer patients who are needed to receive treatment;

• Serious uncontrolled infectious diseases(eg.tuberculosis or invasive pulmonary aspergillosis）；

• Active heart disease